BioOrbit is space manufacturing company developing hardware for the large-scale crystallisation of protein drugs.
BioOrbit has raised €11M across 1 funding round from 7 investors, most recently a Seed round in Apr 2026. Based in London, UK; active in Space. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-30 | Seed | €11M |
| 7 percent,Angel Investors,Auxxo,Breega,LocalGlobe,Seedcamp+1 more |
| View deal → |
